Advanced search

Evaluation of the role of germline RECQL variants in Belgian patients referred for genetic testing in the context of familial breast/ovarian cancer

Greet Wieme (UGent) , Ilse Coene (UGent) , Liselotte Vergote, Bruce Poppe (UGent) , Fransiska Malfait (UGent) , Tom Van Maerken (UGent) , Kim De Leeneer (UGent) and Kathleen Claes (UGent)
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Wieme, Greet, Ilse Coene, Liselotte Vergote, Bruce Poppe, Fransiska Malfait, Tom Van Maerken, Kim De Leeneer, and Kathleen Claes. 2016. “Evaluation of the Role of Germline RECQL Variants in Belgian Patients Referred for Genetic Testing in the Context of Familial Breast/ovarian Cancer.” In Spring Course Hereditary Cancer Genetics.
APA
Wieme, G., Coene, I., Vergote, L., Poppe, B., Malfait, F., Van Maerken, T., De Leeneer, K., et al. (2016). Evaluation of the role of germline RECQL variants in Belgian patients referred for genetic testing in the context of familial breast/ovarian cancer. Spring course Hereditary Cancer Genetics. Presented at the Spring course Hereditary Cancer Genetics.
Vancouver
1.
Wieme G, Coene I, Vergote L, Poppe B, Malfait F, Van Maerken T, et al. Evaluation of the role of germline RECQL variants in Belgian patients referred for genetic testing in the context of familial breast/ovarian cancer. Spring course Hereditary Cancer Genetics. 2016.
MLA
Wieme, Greet et al. “Evaluation of the Role of Germline RECQL Variants in Belgian Patients Referred for Genetic Testing in the Context of Familial Breast/ovarian Cancer.” Spring Course Hereditary Cancer Genetics. 2016. Print.
@inproceedings{8600150,
  author       = {Wieme, Greet and Coene, Ilse and Vergote, Liselotte and Poppe, Bruce and Malfait, Fransiska and Van Maerken, Tom and De Leeneer, Kim and Claes, Kathleen},
  booktitle    = {Spring course Hereditary Cancer Genetics},
  location     = {Bertinoro, Italy},
  title        = {Evaluation of the role of germline RECQL variants in Belgian patients referred for genetic testing in the context of familial breast/ovarian cancer},
  year         = {2016},
}